190 related articles for article (PubMed ID: 35276993)
1. An Infant Formula with Large, Milk Phospholipid-Coated Lipid Droplets Supports Adequate Growth and Is Well-Tolerated in Healthy, Term Asian Infants: A Randomized, Controlled Double-Blind Clinical Trial.
Teoh OH; Lin TP; Abrahamse-Berkeveld M; Winokan A; Chong YS; Yap F; Marintcheva-Petrova M; van der Beek EM; Shek LP
Nutrients; 2022 Feb; 14(3):. PubMed ID: 35276993
[TBL] [Abstract][Full Text] [Related]
2. An infant formula with large, milk phospholipid-coated lipid droplets containing a mixture of dairy and vegetable lipids supports adequate growth and is well tolerated in healthy, term infants.
Breij LM; Abrahamse-Berkeveld M; Vandenplas Y; Jespers SNJ; de Mol AC; Khoo PC; Kalenga M; Peeters S; van Beek RHT; Norbruis OF; Schoen S; Acton D; Hokken-Koelega ACS;
Am J Clin Nutr; 2019 Mar; 109(3):586-596. PubMed ID: 30793165
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of an Infant Formula with Large, Milk-Phospholipid Coated Lipid Droplets on Long-Term Growth and Development of Singaporean Infants: Randomized Controlled Trial Protocol.
Shek LP; Chong YS; Winokan A; Abrahamse-Berkeveld M; Van Der Beek EM; Teoh OH; On Behalf Of The Venus Working Group
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445029
[TBL] [Abstract][Full Text] [Related]
4. A Partly Fermented Infant Formula with Postbiotics Including 3'-GL, Specific Oligosaccharides, 2'-FL, and Milk Fat Supports Adequate Growth, Is Safe and Well-Tolerated in Healthy Term Infants: A Double-Blind, Randomised, Controlled, Multi-Country Trial.
Vandenplas Y; de Halleux V; Arciszewska M; Lach P; Pokhylko V; Klymenko V; Schoen S; Abrahamse-Berkeveld M; Mulder KA; Porcel Rubio R; On Behalf Of The Voyage Study Group
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33233658
[TBL] [Abstract][Full Text] [Related]
5. Infant Milk Formula with Large, Milk Phospholipid-coated Lipid Droplets Enriched in Dairy Lipids Affects Body Mass Index Trajectories and Blood Pressure at School Age: Follow-up of a Randomized Controlled Trial.
Abrahamse-Berkeveld M; Jespers SN; Khoo PC; Rigo V; Peeters SM; van Beek RH; Norbruis OF; Schoen S; Marintcheva-Petrova M; van der Beek EM; Stoelhorst GM; Vandenplas Y; Hokken-Koelega AC;
Am J Clin Nutr; 2024 Jan; 119(1):87-99. PubMed ID: 37973475
[TBL] [Abstract][Full Text] [Related]
6. Fermented infant formula (with Bifidobacterium breve C50 and Streptococcus thermophilus O65) with prebiotic oligosaccharides is safe and modulates the gut microbiota towards a microbiota closer to that of breastfed infants.
Béghin L; Tims S; Roelofs M; Rougé C; Oozeer R; Rakza T; Chirico G; Roeselers G; Knol J; Rozé JC; Turck D
Clin Nutr; 2021 Mar; 40(3):778-787. PubMed ID: 32893049
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal Tolerance, Growth and Safety of a Partly Fermented Formula with Specific Prebiotics in Healthy Infants: A Double-Blind, Randomized, Controlled Trial.
Rodriguez-Herrera A; Mulder K; Bouritius H; Rubio R; Muñoz A; Agosti M; Lista G; Corvaglia L; Ludwig T; Abrahamse-Berkeveld M; Perez-Navero JL
Nutrients; 2019 Jul; 11(7):. PubMed ID: 31284424
[TBL] [Abstract][Full Text] [Related]
8. An Infant Formula with Partially Hydrolyzed Whey Protein Supports Adequate Growth and Is Safe and Well-Tolerated in Healthy, Term Infants: A Randomized, Double-Blind, Equivalence Trial.
Picaud JC; Pajek B; Arciszewska M; Tarczón I; Escribano J; Porcel R; Adelt T; Hassink E; Rijnierse A; Abrahamse-Berkeveld M; Korczowski B; On Behalf Of The Tenuto Study Group
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32668666
[TBL] [Abstract][Full Text] [Related]
9. A partially hydrolyzed formula with synbiotics supports adequate growth and is well tolerated in healthy, Chinese term infants: A double-blind, randomized controlled trial.
Wang Y; Li Z; Wu JL; Zhang L; Liu M; Tan M; Botma A; Liu M; Mulder KA; Abrahamse-Berkeveld M; Cai W
Nutrition; 2021; 91-92():111472. PubMed ID: 34626956
[TBL] [Abstract][Full Text] [Related]
10. Growth and tolerance of formula with lactoferrin in infants through one year of age: double-blind, randomized, controlled trial.
Johnston WH; Ashley C; Yeiser M; Harris CL; Stolz SI; Wampler JL; Wittke A; Cooper TR
BMC Pediatr; 2015 Nov; 15():173. PubMed ID: 26547414
[TBL] [Abstract][Full Text] [Related]
11. Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial.
Ashley C; Johnston WH; Harris CL; Stolz SI; Wampler JL; Berseth CL
Nutr J; 2012 Jun; 11():38. PubMed ID: 22676715
[TBL] [Abstract][Full Text] [Related]
12. Exploration of basal immune parameters in healthy infants receiving an infant milk formula supplemented with prebiotics.
Raes M; Scholtens PA; Alliet P; Hensen K; Jongen H; Boehm G; Vandenplas Y; Rummens JL
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 2):e377-85. PubMed ID: 20003064
[TBL] [Abstract][Full Text] [Related]
13. A novel infant milk formula concept: Mimicking the human milk fat globule structure.
Gallier S; Vocking K; Post JA; Van De Heijning B; Acton D; Van Der Beek EM; Van Baalen T
Colloids Surf B Biointerfaces; 2015 Dec; 136():329-39. PubMed ID: 26432620
[TBL] [Abstract][Full Text] [Related]
14. Randomised controlled trial demonstrates that fermented infant formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides reduces the incidence of infantile colic.
Vandenplas Y; Ludwig T; Bouritius H; Alliet P; Forde D; Peeters S; Huet F; Hourihane J
Acta Paediatr; 2017 Jul; 106(7):1150-1158. PubMed ID: 28328065
[TBL] [Abstract][Full Text] [Related]
15. Partly Fermented Infant Formulae With Specific Oligosaccharides Support Adequate Infant Growth and Are Well-Tolerated.
Huet F; Abrahamse-Berkeveld M; Tims S; Simeoni U; Beley G; Savagner C; Vandenplas Y; Hourihane JO
J Pediatr Gastroenterol Nutr; 2016 Oct; 63(4):e43-53. PubMed ID: 27472478
[TBL] [Abstract][Full Text] [Related]
16. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial.
Kouwenhoven SMP; Antl N; Finken MJJ; Twisk JWR; van der Beek EM; Abrahamse-Berkeveld M; van de Heijning BJM; Schierbeek H; Holdt LM; van Goudoever JB; Koletzko BV
Am J Clin Nutr; 2020 May; 111(5):962-974. PubMed ID: 31868201
[TBL] [Abstract][Full Text] [Related]
17. Safety and tolerance assessment of milk fat globule membrane-enriched infant formulas in healthy term Chinese infants: a randomised multicenter controlled trial.
Jiang B; Xia Y; Zhou L; Liang X; Chen X; Chen M; Li X; Lin S; Zhang N; Zheng L; Tao M; Petocz P; Gallier S; Rowan A; Wang B
BMC Pediatr; 2022 Aug; 22(1):465. PubMed ID: 35918695
[TBL] [Abstract][Full Text] [Related]
18. Infant formula containing galacto-and fructo-oligosaccharides and
Abrahamse-Berkeveld M; Alles M; Franke-Beckmann E; Helm K; Knecht R; Köllges R; Sandner B; Knol J; Ben Amor K; Bufe A
J Nutr Sci; 2016; 5():e42. PubMed ID: 28620469
[TBL] [Abstract][Full Text] [Related]
19. No effect of adding dairy lipids or long chain polyunsaturated fatty acids on formula tolerance and growth in full term infants: a randomized controlled trial.
Gianni ML; Roggero P; Baudry C; Fressange-Mazda C; le Ruyet P; Mosca F
BMC Pediatr; 2018 Jan; 18(1):10. PubMed ID: 29357820
[TBL] [Abstract][Full Text] [Related]
20. Growth and safety evaluation of infant formulae containing oligosaccharides derived from bovine milk: a randomized, double-blind, noninferiority trial.
Meli F; Puccio G; Cajozzo C; Ricottone GL; Pecquet S; Sprenger N; Steenhout P
BMC Pediatr; 2014 Dec; 14():306. PubMed ID: 25527244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
